equity investment Genoox Raises $8M, Names New Board Chair Sumitomo's In Venture subsidiary led the financing round, which Genoox said it will use to broaden its customer base worldwide. Engine Biosciences Closes $43M Series A Round The AI-powered bioinformatics startup will use the money to launch clinical drug discovery programs in precision oncology. Seven Bridges Raises $15M in First Closing of Series C The bioinformatics firm, which did not identify the new investor, expects to close the rest of the $30 million round later this quarter. Seqster Closes $12M Series A Funding Round With investors including 23andMe's Wojcicki, the data aggregation firm is looking to accelerate technology development and company growth. Korean Rare Disease Diagnostics Firm 3billion Looks to 2022 IPO, Expansion Into Drug Discovery Premium Fresh off a $13 million round of venture capital, the company said it sees global potential in analyzing hereditary conditions. Apr 7, 2021 Qlucore Raises SEK 30M as it Looks Toward IPO Apr 6, 2021 Metrion Biosciences Closes £2.7M in Equity Financing Apr 5, 2021 Invitae Acquiring Genosity for $200M; Investment Group Provides Firm $1.15B in Senior Notes Mar 26, 2021 Rare Disease Screening Firm 3billion Closes $13M Series C Financing Mar 17, 2021 M2Gen Lands New Private Investment, Inks Research Deal with Merck Mar 11, 2021 Allelica Raises $1.75M Seed Round, Moves Headquarters to US Mar 2, 2021 Genomics Plc Closes $30M Funding Round Feb 8, 2021 Single-Cell Genomics Firm Analytical Biosciences Inks Partnership, Investment Deal With BioMap Feb 2, 2021 Syapse Raises $68M in Equity Financing Nov 13, 2020 With $50M in New Funding, Congenica Works on Platform Upgrades for Clinical Applications Premium Nov 9, 2020 Congenica Closes $50M Series C Funding Round Oct 26, 2020 GoodCell Raises $17.9M for Analytics Technology, Personal Biobanking Oct 20, 2020 Sophia Genetics Using $110M Funding Round to Focus on New Markets, Continued Collaboration Premium Oct 1, 2020 Sophia Genetics Closes $110M Series F Funding Round Jul 29, 2020 France's DNA Script Extends Series B Financing Round to $89M Jul 29, 2020 Sema4 Raises $121M in Series C Financing Round Jul 28, 2020 Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease Premium Jul 23, 2020 Sanford Health Invests $800K in TruGenomix as Part of PTSD Test Alliance Jul 7, 2020 Cancer AI Startup Nucleai Raises $6.5M in Series A Financing Jun 9, 2020 DNAnexus Lands $100M in New Financing Load More Breaking News Alzheimer's Disease Phosphoproteomics Study Uncovers Signaling Abnormalities Genetic Analysis of H. Pylori Indicates Americas Colonized in One Main Migration Event BillionToOne Raises $55M in Series B Financing GeninCode to Launch Cardiovascular Disease Risk Tests in US With Eversana Top Five Articles on GenomeWeb Last Week: Illumina, Liquid Biopsy, Thermo Fisher Scientific, and More Becton Dickinson Sues Beckman Coulter Over Cell Analysis, Sorting IP The Scan Another Resignation According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug. Novavax Finds Its Vaccine Effective Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19. Can't Be Used The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports. PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.